| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 16:42 | Jefferies upgrades Dr. Reddy's stock rating on margin outlook | ||
| 14:06 | ArriVent reports phase 1 data for cancer drug ARR-217 | ||
| 13:30 | Amarin's icosapent ethyl shows survival benefit in cancer trial | ||
| 12:18 | NovaBridge reports phase 1b data for gastric cancer drug | ||
| 12:18 | Genmab reports phase 2 trial data for colorectal cancer drug | ||
| 11:06 | Brookfield to open Qatar office as it expands Middle East operations | ||
| 09:54 | Xencor reports phase 1 data for cancer drug XmAb819 | ||
| 08:54 | BioNTech, Bristol Myers report lung cancer trial data | ||
| Sa | AU Small Finance Bank Q2'FY27 slides: 53% profit surge, AI gains | ||
| Sa | Parabilis reports phase 1/2 data for desmoid tumor treatment | ||
| Sa | Kotak Q2 FY27 slides: profit jumps 26% as asset quality improves | ||
| Sa | Alaska LNG developer faces scrutiny over funding from sanctioned Russian firm - FT | ||
| Sa | J&J prostate cancer drug shows promising tumor responses in early trial | ||
| Sa | Compass Therapeutics publishes tovecimig trial results in JCO | ||
| Sa | Zymeworks reports trial results for ovarian cancer drug ZW191 | ||
| Sa | Amazon's AWS cloud capacity largely sold out through 2027, CEO says | ||
| Sa | Boeing 777 freighter output halted for two months over supplier row - Reuters | ||
| Sa | U.S. repeatedly asked Musk to restrict or expand Starlink access, Reuters says | ||
| Sa | Therma Bright plans private placement of up to $420,000 | ||
| Sa | Goldcana closes C$1 million flow-through private placement | ||
| Sa | Windward Bio seeks Nasdaq listing to fund respiratory, skin disease drug trials | ||
| Sa | Cathie Wood's ARK sells Alphabet stock, buys Freenome shares | ||
| Sa | How should investors think about GTA VI pre-order performance? | ||
| Sa | SpaceX's $40bn AI debt deal faces hurdles amid credit market turmoil - Bloomberg | ||
| Sa | Graphano Energy amends private placement to add flow-through shares |